# Role of Fibirnogen Like Protein 2 as Aprognostic Factor in High Grade Glioma

> **NCT04113278** · — · UNKNOWN · sponsor: **sohaila Essam** · enrollment: 1 (estimated)

## Conditions studied

- Brain Tumor Adult

## Interventions

- **GENETIC:** FGL2 immunohisyochemistry

## Key facts

- **NCT ID:** NCT04113278
- **Lead sponsor:** sohaila Essam
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-01
- **Primary completion:** 2020-09-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2019-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04113278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04113278, "Role of Fibirnogen Like Protein 2 as Aprognostic Factor in High Grade Glioma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04113278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*